MoneyWorks4Me

The company witnessed a 15.07% growth in the revenue at Rs. 1772.82 millions for the quarter ended June 2026 as compared to Rs. 1540.67 millions during the year-ago period.An average growth of 30.93% was recorded for the quarter ended June 2026 to Rs. 362.34  millions from Rs. 276.75 millions.Operating profit surged to 516.96 millions from the corresponding previous quarter of 390.76 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1772.82 1540.67 15.07 1772.82 1540.67 15.07 6710.30 6232.30 7.67
Other Income 242.65 152.72 58.89 242.65 152.72 58.89 334.54 224.77 48.84
PBIDT 516.96 390.76 32.30 516.96 390.76 32.30 1311.37 1239.71 5.78
Interest 2.59 2.10 23.33 2.59 2.10 23.33 10.13 18.83 -46.20
PBDT 514.37 388.66 32.34 514.37 388.66 32.34 1301.24 1220.88 6.58
Depreciation 38.84 34.77 11.71 38.84 34.77 11.71 145.00 128.99 12.41
PBT 475.53 353.89 34.37 475.53 353.89 34.37 1156.24 1091.89 5.89
TAX 113.19 77.14 46.73 113.19 77.14 46.73 277.31 268.42 3.31
Deferred Tax 59.66 35.91 66.14 59.66 35.91 66.14 -0.31 15.15 -102.05
PAT 362.34 276.75 30.93 362.34 276.75 30.93 878.93 823.47 6.73
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 29.16 25.36 14.97 29.16 25.36 14.97 19.54 19.89 -1.76
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..